Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Largest Study of Melanoma in US Hispanics Reveals California Population in Need of Targeted Prevention Efforts

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

FREMONT, Calif., Sept. 30 /- Scientists at the Cancer Prevention Institute of California (CPIC) , Stanford University, and the University of Southern California/Keck School of Medicine have found that while Hispanics have much lower risks of developing melanoma than non-Hispanic whites in...

Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnson's Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomat...

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Sept. 30 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, according to surveyed European oncologists, Johnson & Johnson's abiraterone will capture greater patient share than...

Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

BRUSSELS, Sept. 30 /- People with Parkinson's disease who used once-daily Neupro® (rotigotine) in the RECOVER trial achieved improvements in quality of life, in addition to previously reported beneficial effects on motor and non-motor symptoms. Data presented this week at the 2nd...

Advertisement

Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., Sept. 30 /- A global pharmaceutical company has initiated a prospective trial to evaluate the impact of insulin guidelines developed by the Indian National Consensus group in collaboration with Max Neeman, a leading India-based Contract Research Organization....

New Study Reveals Collagenase SANTYL® Ointment More Effective Than Hydrogel Dressing for Pressure Ulcer Debridement

September 30, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

FORT WORTH, Texas, Sept. 30 /- Healthpoint today announced that the results of a new study conducted by Catherine T. Milne APRN, MSN, CWOCN, BC-ANP, will be presented on Thursday, September 30, 2010 at 7:15pm (Eastern) at the Healthpoint booth (#110) during the 25th Annual Clinical...

Disparities 2010: Interview with Rep. Elijah Cummings (D-Md.)

September 30, 2010 10:32 am | by AACR | News | Comments

Listen to Rep. Cummings discuss cancer health disparities with the American Association for Cancer Research.

Disparities 2010: Interview with Deborah M. Smith, M.D., M.P.H.

September 30, 2010 10:32 am | by AACR | News | Comments

Listen to Dr. Smith as she speaks with the American Association for Cancer Research on the issue of cancer health disparities.

Disparities 2010: Interview with Joseph D. Rosenblatt, M.D.

September 30, 2010 6:32 am | by AACR | News | Comments

Disparities 2010: Interview with Joseph D. Rosenblatt, M.D., interim director, Sylvester Comprehensive Cancer Center.

Advertisement

Repligen Announces Completion of Patient Enrollment in Phase 2b Clinical Trial of RG2417 for Bipolar Depression

September 30, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., Sept. 30 /- Repligen Corporation (Nasdaq: RGEN ) reported today that it has completed enrollment of patients in its Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression.  This study is a double-blind,...

caprotec bioanalytics Announces Commercial Launch of Three New caproKits™ for Applications in Functional Proteomics and Drug Development

September 30, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

BERLIN and BURLINGTON, Mass., Sept. 30 / - caprotec bioanalytics GmbH announced today the commercial launch of three new caproKits™, enabling the discovery, identification and characterization of proteins for applications in functional proteomics and drug development. The three new...

Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships

September 30, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 30 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has engaged Fabiani & Company to assist in the establishment of federal partnerships...

Winner Medical Launches Its Own PurCotton® B2C Website

September 30, 2010 4:31 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Sept. 30 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner Medical"), a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton® materials for the medical and consumer products industries in China, today announced...

Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R & D Alliance

September 30, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Sept. 30 /- Covance Inc. (NYSE: CVD ) today announced the signing of definitive agreements with sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) for Covance to become sanofi-aventis' R&D partner. Over the next ten years, Covance expects to provide drug development...

Advertisement

MedPro Imaging Launches Ultrasound Transducer Repair Division

September 29, 2010 8:36 am | by Bio-Medicine.Org | News | Comments

WAUKESHA, Wis., Sept. 29 /- MedPro Imaging, a premier provider of economic ultrasound solutions, today announced the launch of its Ultrasound Transducer Repair Division.  Based on proprietary repair technology not previously available in the U.S. market, MedPro Imaging will offer...

African-Americans Equally Likely to Benefit from Erlotinib and Other Targeted Lung Cancer Therapy

September 28, 2010 1:34 pm | by AACR | News | Comments

DENVER — African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors as Caucasians, which suggests they are as likely to benefit from targeted therapies such as erlotinib.

Reportlinker Adds Global Pico Projector By Application, Technology & Products Market (2010-2014)

September 28, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 28 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Pico Projector By Application, Technology & Products Market (2010-2014)....

Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition

September 28, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 28 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition http://www.reportlinker.com/p0304775/Global-In-Vitro-Diagnostics-IVD-Market-Report-2010-Edition.html The global...

Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015

September 28, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 28 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 http://www.reportlinker.com/p0304768/Global-Magnetic-Resonance-Imaging-MRI-Systems-Market-2010---2015.html...

Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results

September 28, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Sept. 28 /- Misonix, Inc. (Nasdaq: MSON ), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, today reported financial results for the fourth fiscal quarter and year ending June 30, 2010....

Reportlinker Adds Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 - 2015".

September 28, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 28 /- Reportlinker.com announces that a new market research report is available in its catalogue: Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 – 2015"....

Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe

September 28, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Sept. 28 /- Luminex Corporation (Nasdaq: LMNX ), today announced the initial dates and locations for the MAGPIX® road show, a multinational tour designed to showcase the recently-launched MAGPIX analytical instrument that is capable of performing up to 50 tests on a...

Millstone Medical Outsourcing Makes Strategic Hires in Memphis

September 28, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

FALL RIVER , Mass., Sept. 28 /- Millstone Medical Outsourcing announced today that the company hired three new professionals to support operations in the Memphis, TN, facility.  Perry C. Rothrock, III, MD, was hired as a consultant to serve as Medical Director.  His role will be...

Open Door Family Medical Centers Named Top Community Health Center in Nation for Use of Information Technology

September 28, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

OSSINING, N.Y., Sept. 28 /- Open Door Family Medical Centers ( http://opendoormedical.org ) a federally qualified community health center providing quality health care to the under-served, uninsured and underinsured residents of Westchester County has received the HIMSS Community Health...

Delcath to Present at the William Blair Emerging Growth Stock Conference

September 28, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 28 /- Delcath Systems, Inc. (Nasdaq: DCTH ) announced today that management will present at the William Blair Emerging Growth Stock Conference on Tuesday, October 5, 2010 at 8:45 a.m. ET in New York, NY. Mr. David McDonald, Chief Financial Officer, will provide an overview...

Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion

September 28, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., Sept. 28 /- Diversifies Revenue Streams and Boosts Scale in Existing Generics Business, and Strengthens Core Pain Franchise Transaction Expected to be Immediately Accretive to Adjusted Diluted Earnings per Share by $0.40 in First Full Year After Close Company Reiterates...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading